A total of 50 Caucasian sexually active women consecutively underwent SIMS for SUI and returned for a 24-month follow-up; demographics are shown in Table 1. At the 24 months follow-up, the stress test was negative in 96% (48/50), 94% (47/50) had PGI-I scores 1 and 2, and 84% (42/50) had PGI-S score 1. Mean ICIQ-SF score decreased from 13.76±2.97 preoperative to 2.26±2.93 at 24 months follow up. No mesh erosion was recognized (Table 1).
A total of 31 patients (62%) showed improvement in total FSFI scores, whereas 9 patients (18%) showed deterioration, and 10 patients (20%) had no changes on the FSFI questionnaire. The mean total FSFI score was statistically significantly improved from 18.85±9.10 to 21.62±8.61. Preoperatively, only 13 patients (26%) had scores showing normal sexual function, while 37 patients (74%) had FSFI total values >26. Following a 24-month follow-up, the number of patients without female sexual dysfunction increased to 38% (19/50). When evaluating the PISQ-12 results, 39 patients (78%) demonstrated an increase in total scores, while 8 patients (16%) demonstrated a decrease, and 3 patients (6%) exhibited no change. The mean total PISQ-12 score was statistically significantly improved from 29.20± 7.30 to 35.26±5.11. If we separate the patients into 2 groups, menopausal (n=35) or not (n=15), we observe the same significant improvement to the mean total FSFI score (15.71±8.48 to 188.37±8.19 and 26,17±5.80 to29.21±2.89) and PISQ-12 score (27,57±6.35 to 33.66±4.87 and 33.00±8.15 to 39.00±3.55) in both groups. (Table 2)
A total of 50 Caucasian sexually active women consecutively underwent SIMS for SUI and returned for a 24-month follow-up; demographics are shown in Table 1. At the 24 months follow-up, the stress test was negative in 96% (48/50), 94% (47/50) had PGI-I scores 1 and 2, and 84% (42/50) had PGI-S score 1. Mean ICIQ-SF score decreased from 13.76±2.97 preoperative to 2.26±2.93 at 24 months follow up. No mesh erosion was recognized (Table 1).
A total of 31 patients (62%) showed improvement in total FSFI scores, whereas 9 patients (18%) showed deterioration, and 10 patients (20%) had no changes on the FSFI questionnaire. The mean total FSFI score was statistically significantly improved from 18.85±9.10 to 21.62±8.61. Preoperatively, only 13 patients (26%) had scores showing normal sexual function, while 37 patients (74%) had FSFI total values >26. Following a 24-month follow-up, the number of patients without female sexual dysfunction increased to 38% (19/50). When evaluating the PISQ-12 results, 39 patients (78%) demonstrated an increase in total scores, while 8 patients (16%) demonstrated a decrease, and 3 patients (6%) exhibited no change. The mean total PISQ-12 score was statistically significantly improved from 29.20± 7.30 to 35.26±5.11. If we separate the patients into 2 groups, menopausal (n=35) or not (n=15), we observe the same significant improvement to the mean total FSFI score (15.71±8.48 to 188.37±8.19 and 26,17±5.80 to29.21±2.89) and PISQ-12 score (27,57±6.35 to 33.66±4.87 and 33.00±8.15 to 39.00±3.55) in both groups. (Table 2)